Frequently Asked Questions

Dendritic Cell therapy is used for various solid tumors or carcinomas, including melanomas and sarcomas. Unlike chemotherapy, which often serves as a supplementary treatment, Dendritic Cell therapy can function as a standalone primary treatment. Its versatility allows for application at any cancer stage, either alongside or independently from other treatments. Our team is committed to assessing your specific situation based on thorough evaluation of your medical reports to determine the most suitable approach for you.

While Dendritic Cell therapy may not yet be widely integrated into the UK's standard treatment protocols, its non-invasive nature and favorable success rates make it an attractive option. Introducing innovative treatments into medical practice requires time, but our dedication to staying at the forefront of cancer therapy ensures that we offer the latest advancements. We understand the importance of patient-centered care and are committed to exploring all viable options to optimise your treatment plan.

The Dendritic Cell therapy process typically spans two to four weeks. During this time, the patient is required for a blood draw and serum injection. This streamlined treatment timeline allows for efficient delivery of therapy while minimizing disruption to your daily life.

We provide personalized proposals tailored to each individual’s specific condition. To receive a comprehensive assessment of the costs associated with Dendritic Cell therapy for your situation, please request a proposal from our team.

Dendritic Cell therapy offers a non-invasive alternative to chemotherapy and does not preclude you from pursuing other standard treatments such as chemotherapy. Our goal is to provide you with a comprehensive range of treatment options and support you in making informed decisions that align with your preferences and health needs.

Early administration of Dendritic Cell therapy is highly advantageous, as it allows your immune system to mount a robust response against cancer cells. By initiating therapy at the earliest possible stage, we maximize the effectiveness of treatment and improve your chances of long-term success.

Our services are designed to accommodate your needs and preferences. Whether you prefer the convenience of receiving treatment at home or the comprehensive care provided at our partner clinics in the UK or in Europe, we offer flexible options to ensure that you receive the highest quality of care tailored to your individual circumstances.

Stem cell therapy involves using stem cells to replace or repair damaged cells or tissues in the body. Stem cells have the unique ability to develop into different types of cells, making them valuable for regenerative medicine.

In immunology, stem cell therapy can help modulate the immune system, either by suppressing an overactive immune response in conditions like autoimmune diseases or by enhancing the immune response against cancer cells.

Stem cell therapy has been used safely for various medical conditions, but it's essential to ensure that it's performed by highly qualified professionals in accredited facilities to minimize risks and maximize benefits.

Stem cell therapy shows promise in treating a range of autoimmune diseases like multiple sclerosis, rheumatoid arthritis, and lupus, as well as in boosting the immune system’s response to cancer through techniques like hematopoietic stem cell transplantation.

Stem cell therapy offers the potential for long-term disease management and even disease reversal in some cases. It can reduce the need for long-term medication and improve overall quality of life for patients with immunological conditions.

CIK therapy stands for Cytokine-Induced Killer cell therapy. It's a type of immunotherapy that involves expanding a patient’s own immune cells in the laboratory and then infusing them back into the body to target and kill cancer cells.

CIK therapy activates a broader range of immune cells, including T cells, NK cells, and other cytotoxic lymphocytes, making it a versatile and potent treatment option for various types of cancer.

CIK therapy has shown great results, particularly for solid tumors like lung cancer, breast cancer, and liver cancer. It can improve survival rates and quality of life in patients.

Side effects of CIK therapy are usually mild and temporary, similar to those of other immunotherapies, such as flu-like symptoms or mild fatigue.

CIK therapy is typically administered through intravenous infusion. The treatment schedule and duration may vary depending on the individual patient and the type of cancer being treated.